Biotech Growth N V - Oct 31, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
10%+ Owner
Signature
By: /s/Ivo Betschart
Stock symbol
BDTX
Transactions as of
Oct 31, 2022
Transactions value $
$224,912
Form type
4
Date filed
11/2/2022, 03:10 PM
Previous filing
Oct 31, 2022
Next filing
Jun 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDTX Common Stock Purchase $225K +99.8K +1.89% $2.25 5.38M Oct 31, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.